David Jegou

667 total citations
25 papers, 486 citations indexed

About

David Jegou is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, David Jegou has authored 25 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Surgery and 8 papers in Oncology. Recurrent topics in David Jegou's work include Chronic Disease Management Strategies (3 papers), Colorectal Cancer Screening and Detection (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). David Jegou is often cited by papers focused on Chronic Disease Management Strategies (3 papers), Colorectal Cancer Screening and Detection (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). David Jegou collaborates with scholars based in France, Belgium and Ireland. David Jegou's co-authors include Sophie Grabar, J.-L. Briard, Freddy Penninckx, E. Van Eycken, Claude Bertrand, Yann-Érick Claessens, Jocelyne de Rotrou, É. Wenisch, V. Faucounau and Anne‐Sophie Rigaud and has published in prestigious journals such as Cancer Research, Spine and International Journal of Cancer.

In The Last Decade

David Jegou

25 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Jegou France 13 156 151 107 78 76 25 486
Craig Tenner United States 11 51 0.3× 123 0.8× 115 1.1× 84 1.1× 24 0.3× 24 393
Eghlim Nemati Iran 15 116 0.7× 199 1.3× 77 0.7× 35 0.4× 30 0.4× 47 605
Jacqueline Kwan Yuk Yuen Hong Kong 13 100 0.6× 157 1.0× 89 0.8× 245 3.1× 45 0.6× 28 736
Deya Marzouk United Kingdom 10 109 0.7× 79 0.5× 99 0.9× 71 0.9× 5 0.1× 19 379
Niall Breslin Ireland 18 551 3.5× 147 1.0× 90 0.8× 32 0.4× 13 0.2× 60 898
Jennifer Welch United States 15 65 0.4× 65 0.4× 124 1.2× 24 0.3× 14 0.2× 56 610
Colin Macleod United States 10 258 1.7× 133 0.9× 128 1.2× 12 0.2× 19 0.3× 21 629
Mary McGraw United Kingdom 14 134 0.9× 51 0.3× 23 0.2× 30 0.4× 54 0.7× 27 644
Åsa H. Everhov Sweden 16 316 2.0× 427 2.8× 141 1.3× 21 0.3× 16 0.2× 56 807

Countries citing papers authored by David Jegou

Since Specialization
Citations

This map shows the geographic impact of David Jegou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jegou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jegou more than expected).

Fields of papers citing papers by David Jegou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jegou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jegou. The network helps show where David Jegou may publish in the future.

Co-authorship network of co-authors of David Jegou

This figure shows the co-authorship network connecting the top 25 collaborators of David Jegou. A scholar is included among the top collaborators of David Jegou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Jegou. David Jegou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomez‐Roca, Carlos, Stéphane Champiat, Philippe A. Cassier, et al.. (2024). Abstract CT181: First-in-human phase I of anti-VISTA monoclonal antibody W0180 with and without anti-PD-1 pembrolizumab in patients with locally advanced or metastatic solid tumors. Cancer Research. 84(7_Supplement). CT181–CT181. 4 indexed citations
2.
Jegou, David, Cécile Dubois, Sabine Stordeur, et al.. (2018). Use of health insurance data to identify and quantify the prevalence of main comorbidities in lung cancer patients. Lung Cancer. 125. 238–244. 12 indexed citations
3.
Vrijens, France, Leen Verleye, Cindy De Gendt, et al.. (2016). Quality Indicators for the management of lung cancer. 2 indexed citations
4.
Jegou, David, et al.. (2016). Seasonal variation in cutaneous melanoma incidence, link with recent UV levels. Melanoma Research. 26(2). 195–201. 2 indexed citations
5.
Savoye, Isabelle, David Jegou, Marina Kvaskoff, et al.. (2015). Is melanoma survival influenced by month of diagnosis?. Cancer Epidemiology. 39(5). 727–733. 4 indexed citations
6.
Jegou, David, et al.. (2015). Seasonal variation in cutaneous melanoma incidence: link with recent UV exposure. A Belgian population-based study. Archives of Public Health. 73(S1). 7 indexed citations
7.
Jegou, David, et al.. (2014). Completeness and registration bias in PROCARE, a Belgian multidisciplinary project on cancer of the rectum with participation on a voluntary basis. European Journal of Cancer. 51(9). 1099–1108. 19 indexed citations
8.
Joye, Ines, et al.. (2014). Does a central review platform improve the quality of radiotherapy for rectal cancer? Results of a national quality assurance project. Radiotherapy and Oncology. 111(3). 400–405. 21 indexed citations
9.
Scatton, Olivier, Stéphane Zalinski, David Jegou, et al.. (2011). Randomized clinical trial of ischaemic preconditioning in major liver resection with intermittent Pringle manoeuvre. British journal of surgery. 98(9). 1236–1243. 44 indexed citations
10.
Rotrou, Jocelyne de, V. Faucounau, É. Wenisch, et al.. (2010). Do patients diagnosed with Alzheimer's disease benefit from a psycho‐educational programme for family caregivers? A randomised controlled study. International Journal of Geriatric Psychiatry. 26(8). 833–842. 66 indexed citations
11.
Claessens, Yann-Érick, G. Kierzek, Sophie Grabar, et al.. (2010). Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Intensive Care Medicine. 36(5). 799–809. 40 indexed citations
12.
Dulioust, Emmanuel, Marianne Leruez‐Ville, Juliette Guibert, et al.. (2010). No detection of HIV 1-RNA in semen of men on efficient HAART in the past 4 years of a 2002–2009 survey. AIDS. 24(10). 1595–1598. 13 indexed citations
13.
Atallah, A., et al.. (2009). Surgical management of a combined fracture of the odontoid process with an atlas posterior arch disruption: A review of four cases. Orthopaedics & Traumatology Surgery & Research. 95(3). 224–228. 9 indexed citations
14.
Bloch, Frédéric, David Jegou, Jean-François Dhainaut, et al.. (2009). Can metabolic abnormalities after a fall predict short term mortality in elderly patients?. European Journal of Epidemiology. 24(7). 357–362. 11 indexed citations
15.
Bloch, Frédéric, David Jegou, Jean-François Dhainaut, et al.. (2009). Do ED staffs have a role to play in the prevention of repeat falls in elderly patients?. The American Journal of Emergency Medicine. 27(3). 303–307. 28 indexed citations
16.
17.
Launay, Odile, Sophie Grabar, Emmanuel Gordien, et al.. (2008). Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(3). 272–275. 51 indexed citations
18.
Launay, Odile, Sophie Grabar, Frédéric Bloch, et al.. (2008). Effect of sublingual administration of interferon-α on the immune response to influenza vaccination in institutionalized elderly individuals. Vaccine. 26(32). 4073–4079. 18 indexed citations
19.
Jegou, David, et al.. (1977). [Pyogenic spondylitis in adults].. PubMed. 62(7). 703–19. 5 indexed citations
20.
Langlois, Jean, et al.. (1971). Traumatic rupture of the thoracic aorta and of its branches.. PubMed. 12(2). 83–92. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Tenner Breakdown of academic impact, for papers by Eghlim Nemati Breakdown of academic impact, for papers by Jacqueline Kwan Yuk Yuen Breakdown of academic impact, for papers by Deya Marzouk Breakdown of academic impact, for papers by Niall Breslin Breakdown of academic impact, for papers by Jennifer Welch Breakdown of academic impact, for papers by Colin Macleod Breakdown of academic impact, for papers by Mary McGraw Breakdown of academic impact, for papers by Åsa H. Everhov
Rankless by CCL
2026